1. Identification of Hypoxia Prognostic Signature in Glioblastoma Multiforme Based on Bulk and Single-Cell RNA-Seq
   Yaman B. Ahmed et al, 2024, Cancers CrossRef
2. A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options
   Fang Yuan et al, 2024, Frontiers in Immunology CrossRef
3. Perspectives on the nanocarriers with miRNAs for targeting melanoma stemness through epigenetic regulation
   Junqi Liu et al, 2023, Pigment Cell & Melanoma Research CrossRef
4. Endothelial cell-specific molecule 1 drives cervical cancer progression
   Jingjing Lu et al, 2022, Cell Death & Disease CrossRef
5. ESM1 May Be Used as a New Indicator for the Diagnosis and Prognosis of Early and Advanced Stage Digestive Tract Cancers
   Kui Kang et al, 2024, International Journal of General Medicine CrossRef
6. Sleep apnoea increases biomarkers of immune evasion, lymphangiogenesis and tumour cell aggressiveness in high-risk patients and those with established lung cancer
   Carolina Cubillos-Zapata et al, 2024, ERJ Open Research CrossRef
7. Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms
   Jan Korbecki et al, 2021, International Journal of Molecular Sciences CrossRef
8. Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cells
   Lijun Xie et al, 2024, PLOS ONE CrossRef
9. Endothelial cell specific molecule 1 promotes epithelial-mesenchymal transition of cervical cancer via the E-box binding homeobox 1
   Jie Qi et al, 2024, PLOS ONE CrossRef
10. Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer
    Iris C. Salaroglio et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
11. The road of NSCLC stem cells toward bone metastases
    Giulia Bertolini et al, 2022, Bone Reports CrossRef
12. Roles of endothelial cell specific molecule‑1 in tumor angiogenesis (Review)
    Jie Zhou et al, 2024, Oncology Letters CrossRef
13. Lactate drives the ESM1–SCD1 axis to inhibit the antitumor CD8+ T-cell response by activating the Wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance
    Zhiwen Fan et al, 2024, International Immunopharmacology CrossRef
14. Intermittent hypoxia BMSCs-derived exosomal miR-31-5p promotes lung adenocarcinoma development via WDR5-induced epithelial mesenchymal transition 
    Jie Ren, 2023, Sleep and Breathing CrossRef
15. MiR-142-3p as an Indicator of OSA Severity Predicts Prognosis in Lung Adenocarcinoma with OSA
    Ting Yang et al, 2022, Nature and Science of Sleep CrossRef
16. CD44 and its implication in neoplastic diseases
    Yiming Xu et al, 2024, MedComm CrossRef
17. Impact of obstructive sleep apnea risk on prognosis and treatment responses of lung cancer
    Sezgi Şahin Duyar et al, 2024, Journal of Medicine and Palliative Care CrossRef
18. Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell‐specific molecule 1 expression
    Peng Zhao et al, 2024, Molecular Carcinogenesis CrossRef
19. Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer
    Nicholas Adzibolosu et al, 2023, Frontiers in Immunology CrossRef
20. Hypoxia-inducible factor 1-alpha is a driving mechanism linking chronic obstructive pulmonary disease to lung cancer
    Yuan-rui Xu et al, 2022, Frontiers in Oncology CrossRef
21. EMS1/DLL4-Notch Signaling Axis Augments Cell Cycle-Mediated Tumorigenesis and Progress in Human Adrenocortical Carcinoma
    Yu-Gang Huang et al, 2021, Frontiers in Oncology CrossRef